SAMR punishes drug wholesalers for price-fixing cancer treatment injections
China’s antitrust watchdog has fined two drug wholesalers €7.5 million for price-fixing and dividing the market for a cancer treatment injection, continuing its aggressive enforcement in the pharmaceutical sector.
To read more
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.